{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:49:31Z","timestamp":1781534971183,"version":"3.54.5"},"reference-count":38,"publisher":"Archives of Endocrinology and Metabolism","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,30]]},"DOI":"10.20945\/2359-3997000000627","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T13:51:32Z","timestamp":1685541092000},"source":"Crossref","is-referenced-by-count":7,"title":["Dual-energy X-ray absorptiometry and adiposity index are sensitive methods to evaluate central fat accumulation in women with polycystic ovary syndrome and normal body mass index"],"prefix":"10.20945","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2860-846X","authenticated-orcid":false,"given":"Gislaine Satyko","family":"Kogure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8753-7975","authenticated-orcid":false,"given":"Victor Barbosa","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-9574","authenticated-orcid":false,"given":"Maria C\u00e9lia","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9308-8344","authenticated-orcid":false,"given":"Rui Alberto","family":"Ferriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8711-8225","authenticated-orcid":false,"given":"Cristiana Libardi Miranda","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9631-4167","authenticated-orcid":false,"given":"Rosana Maria dos","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"1","key":"key20230531095125_B1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","unstructured":"1 Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6-15.","journal-title":"Fertil Steril"},{"key":"key20230531095125_B2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","unstructured":"2 Teede H, Deeks A, Moran L. Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010; 8:413.","journal-title":"BMC Med"},{"issue":"6","key":"key20230531095125_B3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1590\/S0100-72032011000600008","article-title":"Anormalidades metab\u00f3licas em mulheres com s\u00edndrome dos ov\u00e1rios polic\u00edsticos: obesas e n\u00e3o obesas","volume":"33","author":"Romano","year":"2011","unstructured":"3 Romano LGM, Bedoschi G, Melo AS, Albuquerque FO, Silva ACJ, Ferriani RA, et al. Anormalidades metab\u00f3licas em mulheres com s\u00edndrome dos ov\u00e1rios polic\u00edsticos: obesas e n\u00e3o obesas. Rev Bras Ginecol Obstet. 2011;33(6):310-6.","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"2","key":"key20230531095125_B4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s40200-018-0371-5","article-title":"Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach","volume":"17","author":"Toosy","year":"2018","unstructured":"4 Toosy S, Sodi R, Pappachan JM. Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach. J Diabetes Metab Disord. 2018;17(2):277-85.","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"key20230531095125_B5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/09513590.2017.1342793","article-title":"Testosterone is associated with insulin resistance index independently of adiposity in women with polycystic ovary syndrome","volume":"34","author":"Luotola","year":"2018","unstructured":"5 Luotola K, Piltonen TT, Puurunen J, Morin-Papunen LC, Tapanainen JS. Testosterone is associated with insulin resistance index independently of adiposity in women with polycystic ovary syndrome. Gynecol Endocrinol. 2018;34(1):40-4.","journal-title":"Gynecol Endocrinol"},{"issue":"7","key":"key20230531095125_B6","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1210\/jc.2006-2725","article-title":"Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance","volume":"92","author":"Carmina","year":"2007","unstructured":"6 Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Orio F, et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab. 2007;92(7):2500-5.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20230531095125_B7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1385\/JCD:6:2:75","article-title":"Clinical applications of body composition measurements using DXA","volume":"6","author":"Albanese","year":"2003","unstructured":"7 Albanese CV, Diessel E, Genant HK. Clinical applications of body composition measurements using DXA. J Clin Densitom. 2003;6(2):75-85.","journal-title":"J Clin Densitom"},{"issue":"5","key":"key20230531095125_B8","article-title":"Abdominal obesity and cardiovascular risk: performance of anthropometric indexes in women","volume":"92","author":"Almeida","year":"2009","unstructured":"8 Almeida RT, Almeida MM, Ara\u00fajo TM. Abdominal obesity and cardiovascular risk: performance of anthropometric indexes in women. Arq Bras Cardiol. 2009;92(5):345-50, 362-7, 375-80.","journal-title":"Arq Bras Cardiol"},{"key":"key20230531095125_B9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2261-5-26","article-title":"The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: A population-based comparison","volume":"5","author":"Kahn","year":"2005","unstructured":"9 Kahn HS. The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: A population-based comparison. BMC Cardiovasc Disord. 2005;5:26.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"key20230531095125_B10","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/dc09-1825","article-title":"Visceral adiposity index: A reliable indicator of visceral fat function associated with cardiometabolic risk","volume":"33","author":"Amato","year":"2010","unstructured":"10 Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral adiposity index: A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920-2.","journal-title":"Diabetes Care"},{"issue":"1","key":"key20230531095125_B11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"11 Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004 Jan;81(1):19-25.","journal-title":"Fertil Steril"},{"issue":"2","key":"key20230531095125_B12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.diabres.2005.10.017","article-title":"The threshold value for insulin resistance (HOMA-IR) in an admixtured population. IR in the Brazilian Metabolic Syndrome Study","volume":"72","author":"Geloneze","year":"2006","unstructured":"12 Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN. The threshold value for insulin resistance (HOMA-IR) in an admixtured population. IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract. 2006;72(2):219-20.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"key20230531095125_B13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","unstructured":"13 Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.","journal-title":"Clin Chem"},{"issue":"11","key":"key20230531095125_B14","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1210\/jc.2006-0399","article-title":"Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome","volume":"91","author":"Cascella","year":"2006","unstructured":"14 Cascella T, Palomba S, Tauchmanov\u00e0 L, Manguso F, Di Biase S, Labella D, et al. Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2006;91(11):4395-400.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20230531095125_B15","article-title":"Lipid accumulation product and visceral adiposity \u0131ndex: two new indices to predict metabolic syndrome in chronic kidney disease","author":"Biyik","year":"2019","unstructured":"15 Biyik Z, Guney I. Lipid accumulation product and visceral adiposity \u0131ndex: two new indices to predict metabolic syndrome in chronic kidney disease. Eur Rev Med Pharmacol Sci. 2019.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"key20230531095125_B16","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/humrep\/den211","article-title":"Obesity, body composition and metabolic disturbances in polycystic ovary syndrome","volume":"23","author":"Svendsen","year":"2008","unstructured":"16 Svendsen P, Nilas L, Norgaard K, Jensen JE, Madsbad S. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Hum Reprod. 2008;23(9):2113-21.","journal-title":"Hum Reprod"},{"issue":"2","key":"key20230531095125_B17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/jhrs.JHRS_2_19","article-title":"Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome","volume":"12","author":"Satyaraddi","year":"2019","unstructured":"17 Satyaraddi A, Cherian K, Kapoor N, Kunjummen A, Kamath M, Thomas N, et al. Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome. J Hum Reprod Sci. 2019;12(2):78.","journal-title":"J Hum Reprod Sci"},{"issue":"11","key":"key20230531095125_B18","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1210\/jc.2016-2586","article-title":"Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women","volume":"101","author":"Dumesic","year":"2016","unstructured":"18 Dumesic DA Akopians AL, Madrigal VK, Ramirez E, Margolis DJ, Sarma MK, et al. Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. J Clin Endocrinol Metab. 2016;101(11):4178-88.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20230531095125_B19","doi-asserted-by":"crossref","DOI":"10.20945\/2359-3997000000157","article-title":"Association of measures of central fat accumulation indices with body fat distribution and metabolic, hormonal, and inflammatory parameters in women with polycystic ovary syndrome","author":"Ribeiro","year":"2019","unstructured":"19 Ribeiro VB, Kogure GS, Lopes IP, Silva RC, Pedroso DCC, Ferriani RA, et al. Association of measures of central fat accumulation indices with body fat distribution and metabolic, hormonal, and inflammatory parameters in women with polycystic ovary syndrome. Arch Endocrinol Metab. 2019.","journal-title":"Arch Endocrinol Metab"},{"issue":"5","key":"key20230531095125_B20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40618-016-0582-x","article-title":"Visceral adiposity index levels in overweight and\/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters","volume":"40","author":"Durmus","year":"2017","unstructured":"20 Durmus U, Duran C, Ecirli S. Visceral adiposity index levels in overweight and\/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters. J Endocrinol Invest. 2017;40(5):487-97.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"key20230531095125_B21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/met.2020.0045","article-title":"The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome","volume":"19","author":"de Medeiros","year":"2021","unstructured":"21 de Medeiros SF, de Medeiros MAS, Barbosa BB, Yamamoto MMW. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome. Metab Syndr Relat Disord. 2021;19(1):18-25.","journal-title":"Metab Syndr Relat Disord"},{"key":"key20230531095125_B22","doi-asserted-by":"crossref","DOI":"10.1007\/s00592-015-0715-2","article-title":"Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype","author":"Du","year":"2015","unstructured":"22 Du T, Yu X, Zhang J, Sun X. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype. Acta Diabetol. 2015.","journal-title":"Acta Diabetol"},{"key":"key20230531095125_B23","doi-asserted-by":"crossref","DOI":"10.1080\/09513590.2018.1519794","article-title":"The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome","author":"Anik Ilhan","year":"2019","unstructured":"23 Anik Ilhan G, Yildizhan B, Pekin T. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome. Gynecol Endocrinol. 2019.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"key20230531095125_B24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12020-019-01912-1","article-title":"Body fat indices as effective predictors of insulin resistance in obese\/non-obese polycystic ovary syndrome women in the Southwest of China","volume":"65","author":"Huang","year":"2019","unstructured":"24 Huang X, Wang Q, Liu T, Pei T, Liu D, Zhu H, et al. Body fat indices as effective predictors of insulin resistance in obese\/non-obese polycystic ovary syndrome women in the Southwest of China. Endocrine. 2019;65(1):81-5.","journal-title":"Endocrine"},{"issue":"8","key":"key20230531095125_B25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1123\/jpah.2018-0256","article-title":"Effects of progressive resistance training on obesity indices in polycystic ovary syndrome and the relationship with telomere length","volume":"16","author":"Kogure","year":"2019","unstructured":"25 Kogure GS, Miranda-Furtado CL, Pedroso DCC, Ribeiro VB, Eiras MC, Silva RC, et al. Effects of progressive resistance training on obesity indices in polycystic ovary syndrome and the relationship with telomere length. J Phys Act Health. 2019;16(8):601-7.","journal-title":"J Phys Act Health"},{"issue":"2","key":"key20230531095125_B26","first-page":"139","article-title":"Anthropometric and body composition analysis of infertile women with polycystic ovary syndrome","volume":"12","author":"Chitme","year":"2017","unstructured":"26 Chitme HR, Al Azawi EAK, Al Abri AM, Al Busaidi BM, Salam ZKA, Al Taie MM, et al. Anthropometric and body composition analysis of infertile women with polycystic ovary syndrome. J Taibah Univ Med Sci. 2017;12(2):139-45.","journal-title":"J Taibah Univ Med Sci"},{"issue":"3","key":"key20230531095125_B27","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ajcn\/72.3.694","article-title":"Healthy percentage body fat ranges: An approach for developing guidelines based on body mass index","volume":"72","author":"Gallagher","year":"2000","unstructured":"27 Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: An approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72(3):694-701.","journal-title":"Am J Clin Nutr"},{"issue":"15","key":"key20230531095125_B28","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","article-title":"The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering","volume":"168","author":"Wildman","year":"2008","unstructured":"28 Wildman RP. The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering. Arch Intern Med. 2008;168(15):1617-24.","journal-title":"Arch Intern Med"},{"key":"key20230531095125_B29","doi-asserted-by":"crossref","first-page":"719050","DOI":"10.1155\/2014\/719050","article-title":"Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth","volume":"2014","author":"Rojas","year":"2014","unstructured":"29 Rojas J, Ch\u00e1vez M, Olivar L, Rojas M, Morillo J, Mej\u00edas J, et al. Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth. Int J Reprod Med. 2014;2014:719050.","journal-title":"Int J Reprod Med"},{"issue":"10","key":"key20230531095125_B30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.29252\/ijrm.16.10.623","article-title":"Body fat percentage is a better marker than body mass index for determining inflammation status in polycystic ovary syndrome","volume":"16","author":"Hestiantoro","year":"2018","unstructured":"30 Hestiantoro A, Hasani RDK, Shadrina A, Situmorang H, Ilma N, Muharam R, et al. Body fat percentage is a better marker than body mass index for determining inflammation status in polycystic ovary syndrome. Int J Reprod Biomed. 2018;16(10):623-8.","journal-title":"Int J Reprod Biomed"},{"issue":"2","key":"key20230531095125_B31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/ijem.IJEM_637_18","article-title":"Obese and non-obese polycystic ovarian syndrome: Comparison of clinical, metabolic, hormonal parameters, and their differential response to clomiphene","volume":"23","author":"Sachdeva","year":"2019","unstructured":"31 Sachdeva G, Gainder S, Suri V, Sachdeva N, Chopra S. Obese and non-obese polycystic ovarian syndrome: Comparison of clinical, metabolic, hormonal parameters, and their differential response to clomiphene. Indian J Endocrinol Metab. 2019;23(2):257-62.","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"key20230531095125_B32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.18203\/2319-2003.ijbcp20160109","article-title":"Serum lipid profile in non-polycystic ovary syndrome and polycystic ovary syndrome women: a comparative and correlational study","volume":"5","author":"Halasawadekar","year":"2016","unstructured":"32 Halasawadekar N, Ramanand J, Ramanand S, Raparti G, Patil P, Shah R, et al. Serum lipid profile in non-polycystic ovary syndrome and polycystic ovary syndrome women: a comparative and correlational study. Int J Basic Clin Pharmacol. 2016;5(1):105-11.","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"4","key":"key20230531095125_B33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.tjog.2019.05.003","article-title":"Dyslipidemia involvement in the development of polycystic ovary syndrome","volume":"58","author":"Liu","year":"2019","unstructured":"33 Liu Q, Xie YJ, Qu LH, Zhang MX, Mo ZC. Dyslipidemia involvement in the development of polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2019;58(4):447-53.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"key20230531095125_B34","first-page":"25","article-title":"The relationship between sex steroids, insulin resistance and body compositions in obese women: A case-control study","volume":"39","author":"Sayln","year":"2020","unstructured":"34 Sayln S, Kutlu R, Kulakslzo\u011flu M. The relationship between sex steroids, insulin resistance and body compositions in obese women: A case-control study. J Med Biochem. 2020;39(1):25-31.","journal-title":"J Med Biochem"},{"issue":"1","key":"key20230531095125_B35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1210\/jcem-53-1-58","article-title":"Transport of steroid hormones: Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma","volume":"53","author":"Dunn","year":"1981","unstructured":"35 Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab.1981;53(1):58-68.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20230531095125_B36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/IJWH.S344542","article-title":"Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment","volume":"14","author":"Xing","year":"2022","unstructured":"36 Xing C, Zhang J, Zhao H, He B. Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment. Int J Womens Health. 2022;14:91-105.","journal-title":"Int J Womens Health"},{"key":"key20230531095125_B37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000494908","article-title":"Obesity and Androgens in Women","volume":"53","author":"Pasquali","year":"2019","unstructured":"37 Pasquali R, Oriolo C. Obesity and Androgens in Women. Front Horm Res. 2019;53:120-34.","journal-title":"Front Horm Res"},{"key":"key20230531095125_B38","doi-asserted-by":"crossref","DOI":"10.1177\/1179558119874042","article-title":"Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies","volume":"13","author":"Barber","year":"2019","unstructured":"38 Barber TM, Hanson P, Weickert MO, Franks S. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042.","journal-title":"Clin Med Insights Reprod Health"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T13:30:51Z","timestamp":1702560651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/dual-energy-x-ray-absorptiometry-and-adiposity-index-are-sensitive-methods-to-evaluate-central-fat-accumulation-in-women-with-polycystic-ovary-syndrome-and-normal-body-mass-index\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,30]]}},"alternative-id":["10.20945\/2359-3997000000627"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000627","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e000627"}}